Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HC Surgical Specialists Ltd ( (SG:1B1) ) has provided an update.
HC Surgical Specialists Ltd reported a profit of S$3.38 million for the first half of the fiscal year 2025, based on revenues of S$9.94 million. Despite a slight decrease in profit due to non-operational losses such as fair value losses on financial instruments, the company declared an interim dividend of S$0.008 per share, showcasing its commitment to shareholder returns. The financial performance reflects a stable yet slightly challenged operational environment, with implications for maintaining investor confidence amid minor profit declines.
More about HC Surgical Specialists Ltd
HC Surgical Specialists Ltd, listed on Singapore’s Catalist, operates in the healthcare industry, focusing on providing surgical services. The company serves the market through its group of subsidiaries, specializing in a range of surgical procedures.
YTD Price Performance: 5.45%
Average Trading Volume: 36,068
Technical Sentiment Consensus Rating: Hold
Current Market Cap: S$42.3M
For detailed information about 1B1 stock, go to TipRanks’ Stock Analysis page.